Mirae Asset Global Investments
IMRX icon

Mirae Asset Global Investments’s Immuneering IMRX Stock Holding History

Mirae Asset Global Investments’s Portfolio IMRX Stock Details IMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.4K Sell
2,894
-474
-14% -$2.4K ﹤0.01% 1525
2026
Q1 		$17.7K Buy
3,368
+230
+7% +$1.18K ﹤0.01% 1446
2025
Q4 		$20.6K Buy
+3,138
New +$20.1K ﹤0.01% 1533
2024
Q1 		– Sell
-11,118
Closed -$81.7K – 2542
2023
Q4 		$81.7K Sell
11,118
-687
-6% -$4.58K ﹤0.01% 2492
2023
Q3 		$90.7K Buy
11,805
+26
+0.2% +$239 ﹤0.01% 2476
2023
Q2 		$119K Buy
+11,779
New +$113K ﹤0.01% 2467

Other funds holding IMRX

S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return
PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
FCC
Flower City Capital Pittsford, New York $227M AUM 23.31% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
BM
Berman McAleer Timonium, Maryland $864M AUM 22.02% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
NFG
Nations Financial Group Cedar Rapids, Iowa $2.09B AUM 34.27% 1-Year Est. Return

Mirae Asset Global Investments's IMRX Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Immuneering (IMRX) stake by 14% in Q2 2026, selling an estimated $2.4K and leaving 2,894 shares worth $14.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1525.

Mirae Asset Global Investments first reported a position in IMRX in Q2 2023 and has held it in 6 quarters since. The position peaked at $119K in Q2 2023. 21 funds tracked by Wall St. Rank hold IMRX as of Q2 2026.

  • Mirae Asset Global Investments held 2,894 shares of Immuneering worth $14.4K as of Q2 2026.
  • Mirae Asset Global Investments sold 474 Immuneering shares in Q2 2026, an estimated $2.4K.
  • Immuneering made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1525 holding.
  • Mirae Asset Global Investments first reported a position in Immuneering in Q2 2023 and has held it in 6 quarters since.
  • Mirae Asset Global Investments's Immuneering position peaked at $119K in Q2 2023.
  • 21 funds tracked by Wall St. Rank held Immuneering as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.